Replies to post #194162 on Elite Pharmaceuticals Inc (ELTP)

[Dr_Thorfin]

Read again
Lasers wasnt only talking abt eli200 but abt eli200 AND OTHER ADF products

[lasers]

$ELTP expecting to follow up ELI200 Jul 14, 2016 approval with several other ADFs approvals ELI-201, ELI201 etc in the 2016/2018 time period.

$ELTP at $38 PPS, with ELI-200 and their other ADFs achieving 20% share of the $12 bil opioid market is doable with a PE=40 in the 2016/2018 time frame. Based on fully diluted 1 billion shs.